U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

Consensus Molecular Subtypes of colorectal cancer are recapitulated in in vitro and in vivo models

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL13158
106 Samples
Download data: CEL
Series
Accession:
GSE100550
ID:
200100550
2.

Consensus Molecular Subtypes of colorectal cancer are recapitulated in in vitro and in vivo models [primary cell lines AMC/Palermo]

(Submitter supplied) Colorectal cancer (CRC) is a highly heterogeneous disease both from a molecular and clinical perspective. Several distinct molecular entities, such as microsatellite instability (MSI), have been defined that make up biologically distinct subgroups with their own clinical course. Recent data indicated that CRC can be best segregated into four groups called Consensus Molecular Subtypes (CMS1-4), which each have a unique biology and gene expression pattern. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL13158
15 Samples
Download data: CEL
Series
Accession:
GSE100549
ID:
200100549
3.

Consensus Molecular Subtypes of colorectal cancer are recapitulated in in vitro and in vivo models [patient tumors and PDX models]

(Submitter supplied) Colorectal cancer (CRC) is a highly heterogeneous disease both from a molecular and clinical perspective. Several distinct molecular entities, such as microsatellite instability (MSI), have been defined that make up biologically distinct subgroups with their own clinical course. Recent data indicated that CRC can be best segregated into four groups called Consensus Molecular Subtypes (CMS1-4), which each have a unique biology and gene expression pattern. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL13158
55 Samples
Download data: CEL
Series
Accession:
GSE100480
ID:
200100480
4.

Consensus Molecular Subtypes of colorectal cancer are recapitulated in in vitro and in vivo models [primary cell lines Hubrecht Institute]

(Submitter supplied) Colorectal cancer (CRC) is a highly heterogeneous disease both from a molecular and clinical perspective. Several distinct molecular entities, such as microsatellite instability (MSI), have been defined that make up biologically distinct subgroups with their own clinical course. Recent data indicated that CRC can be best segregated into four groups called Consensus Molecular Subtypes (CMS1-4), which each have a unique biology and gene expression pattern. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL13158
18 Samples
Download data: CEL
Series
Accession:
GSE100479
ID:
200100479
5.

Consensus Molecular Subtypes of colorectal cancer are recapitulated in in vitro and in vivo models [cell line panel]

(Submitter supplied) Colorectal cancer (CRC) is a highly heterogeneous disease both from a molecular and clinical perspective. Several distinct molecular entities, such as microsatellite instability (MSI), have been defined that make up biologically distinct subgroups with their own clinical course. Recent data indicated that CRC can be best segregated into four groups called Consensus Molecular Subtypes (CMS1-4), which each have a unique biology and gene expression pattern. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL13158
18 Samples
Download data: CEL
Series
Accession:
GSE100478
ID:
200100478
6.

Gene expression profiling of colorectal cancer tissue samples.

(Submitter supplied) We have analyzed the gene expression-based consensus molecular subtypes of colorectal cancer. These samples represent a subset of the total series analyzed.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL17586
174 Samples
Download data: CEL, CHP
Series
Accession:
GSE96528
ID:
200096528
7.

BCL-XL inhibition induces an FGFR4 mediated rescue response in colorectal cancer

(Submitter supplied) The heterogeneous therapy response observed in colorectal cancer is in part due to cancer stem cells (CSCs) that resist chemotherapeutic insults. The anti-apoptotic protein BCL-XL plays a critical role in protecting CSCs from cell death, where its inhibition with high doses of BH3-mimetics can induce apoptosis. To identify pathways that can regulate sensitivity to BCL-XL inhibition, we screened a compound library for synergy with low dose BCL-XL inhibitor A-1155463 and reveal that FGFR4 inhibition effectively sensitizes to A-1155463 both in vitro and in vivo. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18573
2 Samples
Download data: TXT
Series
Accession:
GSE159504
ID:
200159504
8.

Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia

(Submitter supplied) BH3 mimetics are used as an efficient strategy to promote mitochondrial-dependent cell death in blood malignancies, including acute myeloid leukemia (AML). Venetoclax, a potent BCL2 antagonist, is used clinically in combination with hypomethylating agents for the treatment of AML, while various compounds targeting MCL1 are in clinical trials. Yet, drug resistance eventually ensues, highlighting the urgency to understand the underlying mechanisms. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
7 Samples
Download data: CSV
9.

Integrative proteogenomic characterization of colorectal cancer cell lines and primary tumors

(Submitter supplied) Integrative analysis of global RNASeq and proteomic data comparing human colorectal cancer (CRC) cell lines to primary tumors and normal tissues.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
44 Samples
Download data: TXT
10.

Exon array data for patient-matched primary and metastatic colorectal samples

(Submitter supplied) Samples were taken from surgically resected tumor specimens/metastases from patients with colorectal cancer. The expression profiles were determined using the Affymetrix GeneChip Human Exon 1.0 ST Array version 2.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL5175
10 Samples
Download data: CEL
Series
Accession:
GSE90814
ID:
200090814
11.

Venetoclax treatment imparts distinct cell death sensitivity and adaptivity patterns in T cells

(Submitter supplied) BH3 mimetics are increasingly used as anti-cancer therapeutics either alone or in conjunction with other chemotherapies. However, mounting evidence has also demonstrated that BH3 mimetics induce varied amounts of cell death in healthy immune populations. In order to maximize their clinical potential, it is essential to understand how BH3 mimetics affect discrete immune populations and to determine how BH3 mimetic pressure causes immune system adaptation. more...
Organism:
Mus musculus
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24247
16 Samples
Download data: TXT
Series
Accession:
GSE164483
ID:
200164483
12.

Consensus Molecular Subtype predicts differential vulnerability of colorectal cancer to the survivin suppressant YM155 I

(Submitter supplied) Tumor heterogeneity is a major challenge to the treatment of colorectal cancer (CRC). Recently, a transcriptome-based classification was developed, segregating CRC into four consensus molecular subtypes (CMS) with distinct biological and clinical characteristics. Here, we applied the CMS classification on CRC cell lines to identify novel subtype-specific drug vulnerabilities. We combined publicly available transcriptome data from multiple resources to assign 159 CRC cell lines to CMS. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10558
24 Samples
Download data: TXT
Series
Accession:
GSE116529
ID:
200116529
13.

Consensus Molecular Subtype predicts differential vulnerability of colorectal cancer to the survivin suppressant YM155 II

(Submitter supplied) Tumor heterogeneity is a major challenge to the treatment of colorectal cancer (CRC). Recently, a transcriptome-based classification was developed, segregating CRC into four consensus molecular subtypes (CMS) with distinct biological and clinical characteristics. Here, we applied the CMS classification on CRC cell lines to identify novel subtype-specific drug vulnerabilities. We combined publicly available transcriptome data from multiple resources to assign 159 CRC cell lines to CMS. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
12 Samples
Download data: CEL
Series
Accession:
GSE116528
ID:
200116528
14.

Patient-derived xenograft model identifies clinically relevant subtype-specific features of colorectal cancer

(Submitter supplied) Colorectal cancer (CRC) is a heterogeneous disease classified into four consensus molecular subtype (CMSs) with distinct biological and clinical features. This study aims to understand the value of patient-derived xenografts (PDXs) in relation to these CMSs. A total of 42 primary tumors, recurrences and metastases were used to develop PDXs. Detailed genetic analyses were performed on PDXs and corresponding patient tumors to determine relationship and PDX heterogeneity. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL13158
71 Samples
Download data: CEL
Series
Accession:
GSE103340
ID:
200103340
15.

Prognosis of Stage III Colorectal Carcinomas with FOLFOX Adjuvant Chemotherapy can be Predicted by Molecular Subtype

(Submitter supplied) Comparison the mRNA expression profiles of 101 CRC tissues to those from matched 35 non-neoplastic colon mucosal tissues from patients with stage III CRCs treated with FOLFOX adjuvant chemotherapy in each molecular subtype. Gene expression–based subtyping is widely accepted as a relevant source of disease stratification. Results provide important information of molecular marker genes for molecular classification.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10558
136 Samples
Download data: TXT
Series
Accession:
GSE83889
ID:
200083889
16.

Molecular subtypes of metastatic colorectal cancer are predictive of patient response to chemo and targeted therapies

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
124 Samples
Download data: CEL
Series
Accession:
GSE72970
ID:
200072970
17.

Molecular subtypes of metastatic colorectal cancer are predictive of patient response to chemo and targeted therapies (part 2)

(Submitter supplied) We report that previously described molecular subtypes of colorectal cancer are associated with the response to therapy in patients with metastatic disease. We also identified a patient population with high FOLFIRI sensitivity, as indicated by their 2.7-fold longer overall survival when treated with FOLFIRI, as first-line regimen, instead of FOLFOX. Our results demonstrate the interest of molecular classifications to develop tailored therapies for patients with metastatic colorectal cancer.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
56 Samples
Download data: CEL
Series
Accession:
GSE72969
ID:
200072969
18.

Molecular subtypes of metastatic colorectal cancer are predictive of patient response to chemo and targeted therapies (part 1)

(Submitter supplied) We report that previously described molecular subtypes of colorectal cancer are associated with the response to therapy in patients with metastatic disease. We also identified a patient population with high FOLFIRI sensitivity, as indicated by their 2.7-fold longer overall survival when treated with FOLFIRI, as first-line regimen, instead of FOLFOX. Our results demonstrate the interest of molecular classifications to develop tailored therapies for patients with metastatic colorectal cancer.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
68 Samples
Download data: CEL
Series
Accession:
GSE72968
ID:
200072968
19.

Roles of EMT regulator in colon cancer

(Submitter supplied) Isolation and enrichment of cancer stem cells in colorectal carcinoma to study role of epithelial-mesenchymal transition regilators in tumor malignancy.
Organism:
Homo sapiens
Type:
Expression profiling by array
Datasets:
GDS4511 GDS4596
Platform:
GPL570
8 Samples
Download data: CEL, CHP
Series
Accession:
GSE14773
ID:
200014773
20.
Full record GDS4596

Colorectal cancer cell line SW480 response to Snail overexpression

Analysis of SW480 CRC cells stably overexpressing Snail, an EMT activator highly expressed in CRC colonospheres. SW480-Snail cells display most properties of colonospheres, including cell dedifferentiation. Results provide insight into molecular mechanisms underlying EMT-related malignancy.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 2 genotype/variation sets
Platform:
GPL570
Series:
GSE14773
4 Samples
Download data: CEL, CHP
DataSet
Accession:
GDS4596
ID:
4596
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=3|blobid=MCID_6665b9d3ac4a2c1050fedf03|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center